Artal Group as of March 31, 2020
Portfolio Holdings for Artal Group
Artal Group holds 98 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ww Intl (WW) | 10.6 | $251M | 15M | 16.91 | |
| Alibaba Group Holding (BABA) | 6.6 | $156M | 800k | 194.48 | |
| Acceleron Pharma | 5.7 | $135M | 1.5M | 89.87 | |
| Biontech Se (BNTX) | 5.5 | $130M | 2.2M | 58.40 | |
| Alnylam Pharmaceuticals (ALNY) | 5.1 | $120M | 1.1M | 108.85 | |
| Lexicon Pharmaceuticals (LXRX) | 5.0 | $118M | 60M | 1.95 | |
| Moderna (MRNA) | 3.8 | $90M | 3.0M | 29.95 | |
| Beigene (BGNE) | 3.4 | $80M | 650k | 123.11 | |
| Argenx Se (ARGX) | 2.6 | $63M | 475k | 131.73 | |
| Avantor (AVTR) | 2.4 | $56M | 4.5M | 12.49 | |
| Amicus Therapeutics (FOLD) | 2.3 | $55M | 6.0M | 9.24 | |
| Uniqure Nv (QURE) | 2.3 | $55M | 1.2M | 47.45 | |
| Fate Therapeutics (FATE) | 2.0 | $47M | 2.1M | 22.21 | |
| Bank of America Corporation (BAC) | 1.8 | $43M | 2.0M | 21.23 | |
| Black Diamond Therapeutics (BDTX) | 1.8 | $42M | 1.7M | 24.95 | |
| Paypal Holdings (PYPL) | 1.8 | $42M | 440k | 95.74 | |
| Epizyme | 1.7 | $40M | 2.6M | 15.51 | |
| SPDR S&P Biotech (XBI) | 1.6 | $39M | 500k | 77.44 | |
| Schrodinger (SDGR) | 1.6 | $39M | 897k | 43.12 | |
| Industrial SPDR (XLI) | 1.5 | $35M | 600k | 59.01 | |
| Blueprint Medicines (BPMC) | 1.5 | $35M | 600k | 58.48 | |
| Deciphera Pharmaceuticals (DCPH) | 1.4 | $33M | 800k | 41.17 | |
| Zillow Group Inc Cl C Cap Stk (Z) | 1.4 | $32M | 900k | 36.02 | |
| Scholar Rock Hldg Corp (SRRK) | 1.3 | $31M | 2.5M | 12.11 | |
| Morphic Hldg (MORF) | 1.1 | $27M | 1.8M | 14.68 | |
| MasterCard Incorporated (MA) | 1.0 | $24M | 100k | 241.56 | |
| Iovance Biotherapeutics (IOVA) | 0.9 | $23M | 750k | 29.93 | |
| Atara Biotherapeutics (ATRA) | 0.9 | $21M | 2.5M | 8.51 | |
| Fibrogen (FGEN) | 0.9 | $21M | 600k | 34.75 | |
| Gossamer Bio (GOSS) | 0.8 | $18M | 1.8M | 10.15 | |
| Rubius Therapeutics | 0.7 | $17M | 3.9M | 4.45 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.7 | $17M | 600k | 28.77 | |
| BioMarin Pharmaceutical (BMRN) | 0.7 | $17M | 200k | 84.50 | |
| Bridgebio Pharma (BBIO) | 0.7 | $16M | 550k | 29.00 | |
| Principia Biopharma | 0.6 | $15M | 250k | 59.38 | |
| Agios Pharmaceuticals (AGIO) | 0.6 | $14M | 400k | 35.48 | |
| Harpoon Therapeutics | 0.6 | $14M | 1.2M | 11.58 | |
| 21vianet Group (VNET) | 0.6 | $14M | 1.0M | 13.86 | |
| Turning Point Therapeutics I | 0.6 | $13M | 300k | 44.66 | |
| Ascendis Pharma A S (ASND) | 0.5 | $11M | 100k | 112.61 | |
| Uber Technologies (UBER) | 0.5 | $11M | 400k | 27.92 | |
| Trip Com Intl Ltd Sponsored Ad (TCOM) | 0.5 | $11M | 465k | 23.45 | |
| Aurinia Pharmaceuticals (AUPH) | 0.5 | $11M | 750k | 14.51 | |
| Y Mabs Therapeutics (YMAB) | 0.4 | $10M | 400k | 26.10 | |
| Sage Therapeutics (SAGE) | 0.4 | $10M | 350k | 28.72 | |
| Tg Therapeutics (TGTX) | 0.4 | $9.8M | 1.0M | 9.84 | |
| Albireo Pharma | 0.4 | $9.6M | 588k | 16.37 | |
| Clovis Oncology | 0.4 | $9.5M | 1.5M | 6.36 | |
| Springworks Therapeutics (SWTX) | 0.4 | $9.5M | 350k | 27.00 | |
| Denali Therapeutics (DNLI) | 0.4 | $8.8M | 500k | 17.51 | |
| Stoneco (STNE) | 0.4 | $8.7M | 400k | 21.77 | |
| Aravive | 0.4 | $8.4M | 1.5M | 5.76 | |
| Selecta Biosciences (RNAC) | 0.3 | $8.2M | 3.4M | 2.41 | |
| Regenxbio Inc equity us cm (RGNX) | 0.3 | $8.1M | 250k | 32.38 | |
| Tricida | 0.3 | $7.9M | 360k | 22.00 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.3 | $7.1M | 1.3M | 5.49 | |
| Ac Immune Sa (ACIU) | 0.3 | $6.9M | 1.0M | 6.91 | |
| Hookipa Pharma Inc equity (HOOK) | 0.3 | $6.6M | 796k | 8.25 | |
| Melco Crown Entertainment (MLCO) | 0.3 | $6.2M | 500k | 12.40 | |
| Agenus (AGEN) | 0.3 | $6.1M | 2.5M | 2.45 | |
| American Airls (AAL) | 0.3 | $6.1M | 500k | 12.19 | |
| Merus N V (MRUS) | 0.3 | $6.1M | 500k | 12.10 | |
| Alector (ALEC) | 0.3 | $6.0M | 250k | 24.13 | |
| Minerva Neurosciences | 0.3 | $6.0M | 1.0M | 6.02 | |
| Translate Bio | 0.3 | $6.0M | 600k | 9.97 | |
| Replimune Group (REPL) | 0.3 | $6.0M | 600k | 9.97 | |
| Adverum Biotechnologies | 0.2 | $5.9M | 600k | 9.77 | |
| Stoke Therapeutics (STOK) | 0.2 | $5.7M | 250k | 22.90 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.2 | $5.6M | 200k | 27.78 | |
| Accelr8 Technology | 0.2 | $5.0M | 600k | 8.33 | |
| Cyclerion Therapeutics | 0.2 | $4.9M | 1.9M | 2.65 | |
| Spero Therapeutics (SPRO) | 0.2 | $4.7M | 576k | 8.08 | |
| Bluebird Bio (BLUE) | 0.2 | $4.6M | 100k | 45.96 | |
| I Mab (IMAB) | 0.2 | $4.6M | 350k | 13.00 | |
| Krystal Biotech (KRYS) | 0.2 | $4.3M | 100k | 43.24 | |
| Solid Biosciences | 0.2 | $4.3M | 1.8M | 2.39 | |
| 111 Inc ads (YI) | 0.2 | $4.3M | 650k | 6.61 | |
| Trillium Therapeutics, Inc. Cmn | 0.2 | $4.0M | 1.0M | 4.04 | |
| Kura Oncology (KURA) | 0.2 | $4.0M | 400k | 9.95 | |
| Passage Bio (PASG) | 0.2 | $3.9M | 250k | 15.75 | |
| Immunic (IMUX) | 0.2 | $3.8M | 630k | 6.05 | |
| Aptinyx | 0.2 | $3.6M | 1.7M | 2.16 | |
| Akebia Therapeutics (AKBA) | 0.1 | $3.2M | 425k | 7.58 | |
| Prothena (PRTA) | 0.1 | $3.2M | 300k | 10.70 | |
| Tcr2 Therapeutics Inc cs | 0.1 | $3.1M | 400k | 7.74 | |
| Kaleido Biosciences Ord (KLDO) | 0.1 | $3.1M | 501k | 6.15 | |
| Orchard Therapeutics Plc ads | 0.1 | $3.0M | 400k | 7.53 | |
| Syros Pharmaceuticals | 0.1 | $3.0M | 506k | 5.93 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.1 | $3.0M | 500k | 5.99 | |
| Aduro Biotech | 0.1 | $2.7M | 1.0M | 2.74 | |
| Prevail Therapeutics Ord | 0.1 | $2.4M | 200k | 12.19 | |
| Axcella Health Inc equity | 0.1 | $2.1M | 600k | 3.42 | |
| Aeglea Biotherapeutics | 0.1 | $1.9M | 400k | 4.66 | |
| Portola Pharmaceuticals | 0.1 | $1.4M | 200k | 7.13 | |
| Ironwood Pharmaceuticals (IRWD) | 0.0 | $1.1M | 111k | 10.09 | |
| Curis | 0.0 | $1.1M | 1.5M | 0.70 | |
| Rigel Pharmaceuticals (RIGL) | 0.0 | $546k | 350k | 1.56 | |
| Leap Therapeutics | 0.0 | $395k | 250k | 1.58 |
